1.
Blood 3. Changes in blood thiamine levels in healthy adults after a daily 10mg injection of thiamine The experiment was carried out as follows: 10mg of thiamine was given subcutaneously to 10 normal adults in the early morning every day for 9 days. During the experiment, 8 subjects were at their usual light work and the other 2 subjects did moderately heavy work. At the time of determination of the blood thia mine levels carried out before the loading with thiamine, on the 4th, 7th and 10th days of the experiment, the blood thiamine levels gradually increased. In the 8 subjects doing 4. Changes in blood thiamine levels in patients with CNS diseases after a daily 10mg in jection of thiamine Blood thiamine levels in patients with dis eases of the CNS are significantly lower than those in the normal adults and such was first shown to be attributed to the small amount of in the blood thiamine levels in 19 cases, except for cases 1, 2 and 3, was obviously less than in normal adults. The rate was 15.3+2.3 µg/dl in normal adults on the 10th day of the load, while it was 9.2±2.7 ,ug/dl in patients with CNS disorders. This suggests that in many such cases the blood thiamine levels do not increase as they do in normal adults, although in some cases, the levels did increase to the same extent as in the normal adults. Of the exceptional cases, case 1 was a myelosyphilis and case 2 and 3 were acute anterior poliomyelities; and all recovered with treatment.
Of 19 patients in whom a slight increase in the blood thiamine levels was seen, case 4 was an acute myelitis and case 5 a cerebellar tumor, both of whom died; case 6 was a pro gressive spinal muscular atrophy and case 7 an amyotrophic lateral sclerosis, and in both cases the condition deteriorated. The condi tion of the remaining patients was unchanged during the observation period. Figure 5 shows the results in 5 cases of sequelae follow ing cerebral apoplexy, of which the cause and symptoms were almost uniform. In all cases, Here too the increase in the blood thiamine levels was also slight. Figure  7 shows the results with neurosis. Increase in the blood thiamine levels was slight. Diseases such as liver cirrhosis are those in which in crease in the blood thiamine levels is slight despite loading with thiamine. Liver function was tested in the above neurologic diseases, but positive findings were nil.
The fact that increase in the blood thiamine levels is slight even though thiamine loading is continued, is these ascribed to a disorder of the CNS.
5. Urinary thiamine excretion after a daily injection of 10mg thiamine Figure 8 shows the mean value of thiamine excreted in the urine when a 10mg of thiamine was given subcutaneously consecutively to O n this regimen, about half of the dose was excreted into the urine. Urinary thiamine excretion in the cases of diseases of the CNS tended to be greater. Figure  9 shows the results when 1mg of thiamine was given orally.
The measurement of the amount of thiamine (4, 5) reported that thiamine to a certain plays a role in the metabolism of Ca and Mg. It is as sumed that not only is thiamine increased in tissue but Ca also increases in tissue when TPD is given, thus leading to an improvement is seen in nervous function.
CONCLUSION
Blood thiamine levels in disease of the CNS were significantly low and even after consecu tive subcutaneous injections of 10mg of thia mine the increase was only slight when com pared with that of normal adults. Those in whom the increase in blood thiamine level was the same as in the controls had a favorable prognosis. Regarding urinary excretion of thiamine after consecutively loading with thia mine, higher rates were seen in patients with CNS diseases. It would thus appear that the ability to retain thiamine is generally decreased in patients with diseases of the CNS.
When TPD which has stronger affinity with tissue than thiamine was given orally, thiamine levels in the body increased to a greater extent than presumed from the increase in the blood thiamine levels. The ability to retain thiamine in the body is lower in the patients with an unfavorable prognosis in the disease of the CNS, while it is higher in those with a favorable prognosis.
